Status:

UNKNOWN

Jianpi Huoxue Recipe in Treating Gastric Premalignant Lesion

Lead Sponsor:

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Collaborating Sponsors:

Guangdong Provincial Hospital of Traditional Chinese Medicine

Beijing Friendship Hospital

Conditions:

Gastric Precancerous Condition

Eligibility:

All Genders

18-75 years

Phase:

PHASE1

PHASE2

Brief Summary

This study had adopted the multi-center, randomized and controlled experiment design based on standardized mucosal biopsy and pathohistological operation, as well as therapeutic evaluation methodology...

Detailed Description

Intraepithelial neoplasia of gastric mucosa is a well-recognized gastric Premalignant lesion, which is the key of secondary prevention for gastric cancer. However, no universally acknowledged effectiv...

Eligibility Criteria

Inclusion

  • Outpatients and inpatients diagnosed with chronic atrophic gastritis accompanying with low grade intraepithelial neoplasia and indefinite dysphasia confirmed by gastroscopy and histopathological examination;
  • Patients aged from 18-75 years;
  • Subjects who were informed and voluntarily signed the informed consent.

Exclusion

  • Patients pathohistologically diagnosed with high grade intraepithelial neoplasia/severe dysplasia;
  • Patients with a history of gastric ulcer, gastric polyps and gastric surgery;
  • Patients taking NSAIDs for a long term;
  • Patients suspected of gastric cancer or malignant lesions in other systems;
  • Patients with a history of gastric surgery;
  • Patients with concurrent primary diseases in cardiovascular, cerebrovascular, liver, kidney and hemopoietic systems (ALT\>80 u/L, and/or AST\>80 u/L, with abnormal renal function)
  • Patients with mental disease, dysgnosia and logopathy;
  • Pregnant women, or those preparing a pregnancy and breastfeeding women;
  • Patients with a allergic history of medicines used in this experiment.

Key Trial Info

Start Date :

March 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

480 Patients enrolled

Trial Details

Trial ID

NCT03823248

Start Date

March 1 2019

End Date

December 31 2021

Last Update

June 25 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Beijing, China, 100091